Posted on 11/10/2018 6:36:21 PM PST by Olog-hai
Japanese researchers said Friday they have transplanted stem cells into the brain of a patient in the first stage of an innovative trial to cure Parkinsons disease.
The research team at Kyoto University injected induced Pluripotent Stem (iPS) cells which have the potential to develop into any cell in the body into the brain of a male patient in his fifties, the university said in a press release.
The man was stable after the operation, which was performed last month, and he will now be monitored for two years, the university added.
The researchers injected 2.4 million iPS cells into the left side of the patients brain, in an operation that took about three hours. If no problems are observed in the coming six months, they will implant another 2.4 million cells into the right side.
The iPS cells from healthy donors have been developed into the precursors of dopamine-producing brain cells, which are no longer present in people with Parkinsons disease. [ ]
The human trial comes after an earlier trial involving monkeys. [ ]
iPS cells are created by stimulating mature already-specialized cells back into a juvenile state basically cloning without the need for an embryo.
(Excerpt) Read more at afp.com ...
Interesting that the inject them into the more stable masculine logical left hemisphere of the brain before trying the more unstable emotional feminine right hemisphere!!!! Humor intended.
The answer to your question is the epigenetic influence of consciousness on the transcription process.
This is different. These cells have already been started on the process of development in the desired manner.
“The iPS cells from healthy donors have been developed into the precursors of dopamine-producing brain cells”
Exactly as I 'thought'. : )
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.